KRAS and pancreatic ductal adenocarcinoma: Notably, the involvement of YAP in KRAS-mediated neoplastic progression in pancreatic ductal adenocarcinoma (PDAC), underscores the potential crosstalk between YAP/TAZ and RAS signaling pathways in PDAC [35].